Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab in C4d+ Chronic Allograft Nephropathy
NCT00476164Phase 4Completed
- Sponsor
- King's College London
- Start
- Jan 2007
- Primary completion
- May 2015
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of rituximab in Chronic Allograft Kidney Disease (CKaD), sponsored by King's College London. Started Jan 2007; status: completed.
02
Drugs
rituximab
03
Conditions
Chronic Allograft Kidney Disease (CKaD)
Beyond the preview
Go deeper on NCT00476164.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00476164.